Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors

Background: TQ-B3203 is a novel topoisomerase I inhibitor currently in development for the treatment of advanced solid tumors. Great differences in pharmacokinetic characteristics were found among individuals according to the phase I clinical trial following intravenous administration of TQ-B3203 li...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Xiaoqing Li (Dahkki), Yunhai Bo (Dahkki), Han Yin (Dahkki), Xiaohong Liu (Dahkki), Xu Li (Dahkki), Fen Yang (Dahkki)
Materiálatiipa: Girji
Almmustuhtton: Frontiers Media S.A., 2023-01-01T00:00:00Z.
Fáttát:
Liŋkkat:Connect to this object online.
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

Connect to this object online.

3rd Floor Main Library

oažžasuvvan: 3rd Floor Main Library
Hildobáiki: A1234.567
Njađus 1 Oažžumis